These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2558849)

  • 21. The effect of topical ocular corticosteroid administration in dogs with experimentally induced latent canine herpesvirus-1 infection.
    Ledbetter EC; Kice NC; Matusow RB; Dubovi EJ; Kim SG
    Exp Eye Res; 2010 Jun; 90(6):711-7. PubMed ID: 20223234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Investigations on the latent infection of herpes simplex virus-1 in the cornea].
    Xie LX; Dong XG
    Zhonghua Yan Ke Za Zhi; 1993 Mar; 29(2):108-10. PubMed ID: 8404352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of recurrent and primary herpes simplex keratitis in NIH inbred mice.
    Miller JK; Laycock KA; Umphress JA; Hook KK; Stuart PM; Pepose JS
    Cornea; 1996 Sep; 15(5):497-504. PubMed ID: 8862927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of herpes simplex virus type-1 latency in corneas.
    Xie LX; Dong XG; Kaufman HE
    Chin Med J (Engl); 1993 Apr; 106(4):288-91. PubMed ID: 8391970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of latent ganglionic infection with herpes simplex virus via maxillary gingiva and viral re-activation in vivo after trauma.
    Shimizu F; Monma Y; Sekizawa T; Kamiyama K
    J Dent Res; 1989 Mar; 68(3):472-5. PubMed ID: 2537858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible latent infection with herpes simplex virus in the mouse eye.
    Claoué CM; Hodges TJ; Darville JM; Hill TJ; Blyth WA; Easty DL
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2385-90. PubMed ID: 2172451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
    Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HSV-1 infection and immunity in immunosuppressed mice.
    Litwińska B; Sadowski W; Kańtoch M
    Acta Virol; 1987 Aug; 31(4):298-306. PubMed ID: 2892379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
    Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
    J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID).
    Minagawa H; Sakuma S; Mohri S; Mori R; Watanabe T
    Arch Virol; 1988; 103(1-2):73-82. PubMed ID: 2850780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigens of herpes simplex virus in whole corneal epithelial sheets from mice.
    Shimeld C; Lewkowicz-Moss SJ; Lipworth KM; Hill TJ; Blyth WA; Easty DL
    Arch Ophthalmol; 1986 Dec; 104(12):1830-4. PubMed ID: 3024609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants.
    Cook SD; Paveloff MJ; Doucet JJ; Cottingham AJ; Sedarati F; Hill JM
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1558-61. PubMed ID: 1849874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent HSV-1 corneal lesions in rabbits induced by cyclophosphamide and dexamethasone.
    Haruta Y; Rootman DS; Xie LX; Kiritoshi A; Hill JM
    Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):371-6. PubMed ID: 2925310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UV radiation and mouse models of herpes simplex virus infection.
    Norval M; el-Ghorr AA
    Photochem Photobiol; 1996 Aug; 64(2):242-5. PubMed ID: 8760562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targets of herpes simplex virus type 1 infection in a mouse corneal model.
    Martin JR; Jenkins FJ; Henken DB
    Acta Neuropathol; 1991; 82(5):353-63. PubMed ID: 1662854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Previous immunization of mice with herpes simplex virus type-1 strain MP protects against secondary corneal infection.
    Sandstrom IK; Foster CS; Wells PA; Knipe D; Caron L; Greene MI
    Clin Immunol Immunopathol; 1986 Aug; 40(2):326-34. PubMed ID: 3013476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D.
    Wachsman M; Aurelian L; Smith CC; Lipinskas BR; Perkus ME; Paoletti E
    J Infect Dis; 1987 Jun; 155(6):1188-97. PubMed ID: 3033094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains.
    Hemady R; Tauber J; Ihley TM; Opremcak EM; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2335-41. PubMed ID: 2173686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.